Karolinska
Europe, Stockholms Lan, Sweden, Solna
Description
Karolinska Development is an investment firm focused on identifying medical innovation and supporting the creation and growth of companies.
Investor Profile
Karolinska has made 29 investments, with 4 in the past 12 months and 34% as lead.
Stage Focus
- Series Unknown (41%)
- Post Ipo Debt (14%)
- Series A (10%)
- Seed (7%)
- Series B (7%)
- Convertible Note (7%)
- Corporate Round (3%)
- Post Ipo Equity (3%)
- Series C (3%)
- Debt Financing (3%)
Country Focus
- Sweden (72%)
- Finland (10%)
- Denmark (10%)
- United States (7%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Therapeutics
- Clinical Trials
- Biopharma
- Neuroscience
- Medical Device
- Nanotechnology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
